Marsh (MRSH) - 5i Research

Marsh (MRSH $172.15)
- $172.15 P/E (TTM): 20.27X Cap: $82.72B
- View MRSH Profile
- View Questions on MRSH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Marsh (MRSH $172.15)
- $172.15 P/E (TTM): 20.27X Cap: $82.72B
- View MRSH Profile
- View Questions on MRSH

Q: You once wrote "The insurance industry tends to perform well in bear markets or stagnant markets (risk-off environments), as they have durable business models with predictable earnings. We like having exposure to the industry as a form of 'insurance' for those unpredictable times when the broader markets soften." My question is around why MMC is performing so poorly, and is this a buying opportunity?

Read Answer Asked by Neil on March 13, 2026